Literature DB >> 17458918

MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.

Marinette van der Graaf1, Margarida Julià-Sapé, Franklyn A Howe, Anne Ziegler, Carles Majós, Angel Moreno-Torres, Mark Rijpkema, Dionisio Acosta, Kirstie S Opstad, Yvonne M van der Meulen, Carles Arús, Arend Heerschap.   

Abstract

This paper reports on quality assessment of MRS in the European Union-funded multicentre project INTERPRET (International Network for Pattern Recognition of Tumours Using Magnetic Resonance; http://azizu.uab.es/INTERPRET), which has developed brain tumour classification software using in vivo proton MR spectra. The quality assessment consisted of both MR system quality assurance (SQA) and quality control (QC) of spectral data acquired from patients and healthy volunteers. The system performance of the MR spectrometers at all participating centres was checked bimonthly by a short measurement protocol using a specially designed INTERPRET phantom. In addition, a more extended SQA protocol was performed yearly and after each hardware or software upgrade. To compare the system performance for in vivo measurements, each centre acquired MR spectra from the brain of five healthy volunteers. All MR systems fulfilled generally accepted minimal system performance for brain MRS during the entire data acquisition period. The QC procedure of the MR spectra in the database comprised automatic determination of the signal-to-noise ratio (SNR) in a water-suppressed spectrum and of the line width of the water resonance (water band width, WBW) in the corresponding non-suppressed spectrum. Values of SNR > 10 and WBW < 8 Hz at 1.5 T were determined empirically as conservative threshold levels required for spectra to be of acceptable quality. These thresholds only hold for SNR and WBW values using the definitions and data processing described in this article. A final QC check consisted of visual inspection of each clinically validated water-suppressed metabolite spectrum by two, or, in the case of disagreement, three, experienced MR spectroscopists, to detect artefacts such as large baseline distortions, exceptionally broadened metabolite peaks, insufficient removal of the water line, large phase errors, and signals originating from outside the voxel. In the end, 10% of 889 spectra with completed spectroscopic judgement were discarded.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17458918     DOI: 10.1002/nbm.1172

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  8 in total

Review 1.  Multicentre imaging measurements for oncology and in the brain.

Authors:  P S Tofts; D J Collins
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Standardization of Small Animal Imaging-Current Status and Future Prospects.

Authors:  Julia G Mannheim; Firat Kara; Janine Doorduin; Kerstin Fuchs; Gerald Reischl; Sayuan Liang; Marleen Verhoye; Felix Gremse; Laura Mezzanotte; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2018-10       Impact factor: 3.488

3.  The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses.

Authors:  Alexander Pérez-Ruiz; Margarida Julià-Sapé; Guillem Mercadal; Iván Olier; Carles Majós; Carles Arús
Journal:  BMC Bioinformatics       Date:  2010-11-29       Impact factor: 3.169

4.  Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra.

Authors:  Elies Fuster-Garcia; Clara Navarro; Javier Vicente; Salvador Tortajada; Juan M García-Gómez; Carlos Sáez; Jorge Calvar; John Griffiths; Margarida Julià-Sapé; Franklyn A Howe; Jesús Pujol; Andrew C Peet; Arend Heerschap; Angel Moreno-Torres; M C Martínez-Bisbal; Beatriz Martínez-Granados; Pieter Wesseling; Wolfhard Semmler; Jaume Capellades; Carles Majós; Angel Alberich-Bayarri; Antoni Capdevila; Daniel Monleón; Luis Martí-Bonmatí; Carles Arús; Bernardo Celda; Montserrat Robles
Journal:  MAGMA       Date:  2011-01-20       Impact factor: 2.310

5.  Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder.

Authors:  Douglas G Kondo; Tracy L Hellem; Young-Hoon Sung; Namkug Kim; Eun-Kee Jeong; Kristen K Delmastro; Xianfeng Shi; Perry F Renshaw
Journal:  Depress Res Treat       Date:  2010-10-04

6.  Evaluation of the INTERPRET decision-support system: can it improve the diagnostic value of magnetic resonance spectroscopy of the brain?

Authors:  J Hellström; R Romanos Zapata; S Libard; J Wikström; F Ortiz-Nieto; I Alafuzoff; R Raininko
Journal:  Neuroradiology       Date:  2018-11-15       Impact factor: 2.804

7.  1H-MR spectroscopy in grading of cerebral glioma: A new view point, MRS image quality assessment.

Authors:  Tahir M Shakir; Liang Fengli; Guo Chenguang; Niu Chen; Ming Zhang; Ma Shaohui
Journal:  Acta Radiol Open       Date:  2022-02-26

8.  Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy.

Authors:  Juan M García-Gómez; Jan Luts; Margarida Julià-Sapé; Patrick Krooshof; Salvador Tortajada; Javier Vicente Robledo; Willem Melssen; Elies Fuster-García; Iván Olier; Geert Postma; Daniel Monleón; Angel Moreno-Torres; Jesús Pujol; Ana-Paula Candiota; M Carmen Martínez-Bisbal; Johan Suykens; Lutgarde Buydens; Bernardo Celda; Sabine Van Huffel; Carles Arús; Montserrat Robles
Journal:  MAGMA       Date:  2008-11-07       Impact factor: 2.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.